Position in BNTC
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,396,250
-$634,500 QoQ
Shares Held
225,000
0.0% QoQ
Ownership
0.655%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BNTC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MYDA Advisors LLC holds $37,336,697 across 11 Biotechnology names. BNTC ranks #5 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHVN |
Biohaven Ltd.
|
1,225,000 | $10,363,500 | |
| 2 | MANE |
Veradermics, Inc
|
120,000 | $7,578,000 | |
| 3 | ARQT |
Arcutis Biotherapeutics, Inc.
|
240,000 | $5,654,400 | |
| 4 | EYPT |
EyePoint, Inc.
|
330,000 | $4,253,700 | |
| 5 | BNTC |
Benitec Biopharma Inc.
This page
|
225,000 | $2,396,250 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
40,000 | $2,108,800 | |
| 7 | CELC |
Celcuity Inc.
|
15,000 | $1,712,100 | |
| 8 | IMTX |
Immatics N.V.
|
120,000 | $1,180,800 |
All Filings in BNTC
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,396,250 | 225,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $3,030,750 | 225,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $982,100 | 70,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $726,757 | 62,116 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $676,520 | 52,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $631,500 | 50,000 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||